- Datum15.01.2025
- Uhrzeit15:00 - 15:30 Uhr
- Veranstalter
stock3
Thomas May
Moderator
MannKind Corp. Aktie
Verkaufen
Kaufen
MannKind Corp. Chart
stock3 TerminalDu willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnen
MannKind Corp. Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
8,73 %
Intraday
4,74 %
1 Woche
0,15 %
1 Monat
88,19 %
Seit Jahresbeginn
90,28 %
1 Jahr
55,33 %
3 Jahre
392,81 %
5 Jahre
-74,54 %
10 Jahre
Wikifolio
Passender Service zu MannKind Corp.
Webinar zu MannKind Corp.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)3,170-7,630
- Jahrestief / Hoch ($)3,170-7,630
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von MannKind Corp.
Keine Dividenden verfügbar
Termine von MannKind Corp.
- Mär4MannKind Corp.Q4 2024 Earnings Release
- Mai7MannKind Corp.Q1 2025 Earnings Release
- Aug6MannKind Corp.Q2 2025 Earnings Release
Beschreibung
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.
